NovaBlue(DE3) Competent Cells

Components

0.4 ml1 mlComponentr> 2 × 0.2 ml5 × 0.2 mlNovaBlue(DE3) Competent Cellsr> 2 × 2 ml4 × 2 mlSOC Mediumr> 2 ng2 ngTest Plasmid

General description

This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges us to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.

NovaBlue is a K-12 strain ideally suited as an initial cloning host due to its high transformation efficiency, blue/white screening capability (with appropriate plasmids) and recA endA mutations.

NovaBlue(DE3) Competent Cells is a K-12 strain with high transformation efficiency and recA endA mutations. The DE3 lysogen of NovaBlue is potentially useful as a stringent host due to the presence of the lacI^q repressor encoded by the F episome. This product is covered under license from Brookhaven National Labs. Commercial entities need to obtain a research use license prior to purchase. Please contact your licensing department to confirm that your company already holds a research use license.

Legal Information

NOVAGEN is a registered trademark of Merck KGaA, Darmstadt, Germany

Packaging

1 ml in Glass bottle

0.4 ml in Plastic ampoule

Warning

Toxicity: Multiple Toxicity Values, refer to MSDS (O)